Search Results 1351-1360 of 19971 for Hepatitis b

  1. Pevonedistat Plus Azacitidine Versus Single-Agent Azacitidine as First-Line Treatment for Participants With Higher-Risk Myelodysplastic Syndromes (HR MDS), Chronic Myelomonocytic Leukemia (CMML), or Low-Blast Acute Myelogenous Leukemia (AML) - Mayo Clinic

    ... hepatitis B surface antigen and negative hepatitis B surface antibody) must have an undetectable hepatitis B viral load. Has known hepatic cirrhosis or ...

  2. A Study Of The Effectiveness And Safety Of Vedolizumab Compared To Adalimumab For Participants With Ulcerative Colitis - Mayo Clinic

    Has chronic hepatitis B virus (HBV) infection* or chronic hepatitis C virus (HCV) infection (* HBV immune participants, ie, being hepatitis B surface ...

  3. Safety, Efficacy and Tolerability of Ianalumab Versus Placebo, Combination With SoC Therapy, in Participants With Active Lupus Nephritis - Mayo Clinic

    * Chronic infection with hepatitis B (HBV) or hepatitis C (HCV). Positive serology for hepatitis B surface antigen (HBsAg) excludes the participant * ...

  4. A Phase 2 Study of Anti-PD-L1 Antibody Atezolizumab in Alveolar Soft Part Sarcoma - Mayo Clinic

    ... hepatitis; cirrhosis; fatty liver; and inherited liver disease. Patients with past or resolved hepatitis B infection (defined as having a negative hepatitis B ...

  5. A Study of Elotuzumab, Daratumumab, Iberdomide, and Dexamethasone for Relapsed Multiple Myeloma - Mayo Clinic

    ... hepatitis B surface antigen [HBsAg]) at registration or ≤3 months prior to registration. Note: Participants with resolved hepatitis B infection (ie ...

  6. Portal hypertension - Doctors and departments - Mayo Clinic

    ... ...a, Cirrhosis, Alcoholic liver disease, Hepatitis C, Hepatitis B, Nonalcoholic fatty liver disease, Primary biliary cholangitis, Liver tumor ...

  7. Mayo Clinic Podcast - Dr. Gregory Poland YouTube Audio Expor...

    Yeah, so now several of the vaccine manufacturers have done trials, and they're going to do them down to birth age, just like when we give hepatitis B vaccine ...

  8. A Study To Evaluate The Efficacy And Safety Of Obinutuzumab In Patients With ISN/RPS 2003 Class III Or IV Lupus Nephritis - Mayo Clinic

    Positive hepatitis B surface antigen (HBsAg);; Patients who are HBsAg negative and hepatitis B core antibody (HBcAb) positive with no detectable hepatitis B ...

  9. A Study to Assess Safety and Effectiveness of Venetoclax in Combination With Gilteritinib in Subjects With Relapsed/Refractory Acute Myeloid Leukemia - Mayo Clinic

    ... hepatitis B, or hepatitis C. Note: HIV and hepatitis B or C testing is not required and subjects with serologic evidence of prior vaccination to hepatitis B ...

  10. A Pilot Study to Assess the Efficacy of Rituximab Therapy in Treatment Resistant FSGS - Mayo Clinic

    Presence or suspicion of active infection including TB, HIV, Hepatitis B and HCV with positive tests for Hepatitis B surface antigen (HBsAg), Hepatitis B ...